RESUMEN
BACKGROUND: Although combined oral contraceptive (COC) is commonly used in sub-Saharan Africa, data on its cardiovascular disease risk remains scanty. The study aimed to determine serial serum lipid profiles and cardiovascular disease risks among COC-users. METHODS: This is a prospective, comparative multicentered study conducted at four health facilities in Nigeria. Participants were new users of contraceptives; 120 each of women initiating COCs (group I) and those initiating other forms of nonhormonal contraceptives (group II) were recruited and monitored over a 6-month period. Serial lipid profile, blood pressure, and atherogenic risk for cardiovascular diseases were measured at recruitment (start) and scheduled follow-up clinic visits at 3 months and 6 months for all participants. Statistical analysis was performed with SPSS (version 21.0) and P value < 0.05 was considered significant. RESULTS: In all, 225 participants (111 COC-users, 114 nonCOC-users) that completed the study were aged 18 to 49 years. There was a statistically significant increase in the diastolic blood pressure (P = 0.001), Low Density Lipoprotein- Cholesterol (P = 0.038) and higher atherogenic risk (P = 0.001) among COC-users compared to nonCOC-users. The serial total serum cholesterol, triglyceride, High Density Lipoprotein, systolic blood pressure, and body mass index were higher among COC-users but were not statistically significant compared to nonCOC-users. CONCLUSION: Alterations in lipid profile and increased short-term atherogenic risk for cardiovascular disease were reported among the COC-users in this study. Serial lipid profile and atherogenic risk assessment for cardiovascular diseases are recommended for monitoring of COC-users.
Asunto(s)
Enfermedades Cardiovasculares , Enfermedades Cardiovasculares/inducido químicamente , Enfermedades Cardiovasculares/epidemiología , Anticonceptivos Orales Combinados/efectos adversos , Femenino , Factores de Riesgo de Enfermedad Cardiaca , Humanos , Estudios Prospectivos , Factores de RiesgoRESUMEN
Herpes simplex virus type 2 (HSV-2) is the primary cause of genital herpes worldwide and also has a role in facilitating human immunodeficiency virus (HIV) transmission. The aim of the study was to determine seroprevalence of HSV-2 among the subjects and associated risk factors. In this cross-sectional study, 207 HIV Positive subjects attending a retroviral Clinic in Federal Medical Center, Abeokuta, Ogun state were interviewed and had blood samples taken. The patients were interviewed using a structured questionnaire and their serum samples were tested for HSV-2 specific immunoglobulin G (IgG) antibodies using enzyme-linked immunosorbent assay (ELISA) for consented participation. Prevalence of HSV-2 antibodies was ascertained and related to demographics and behavioral variables. A total of 207 participants were recruited for this study comprising of Sixty-three (30.4%) male and 144 (69.6%) female HIV positive subjects. Seroprevalence of HSV-2 was 70.0%. Only 58(28%) had current history of genital ulcer. Logistic regression revealed a history of multiple sexual partners (P value=0.003), oral sex (P value=0.02) were found to be associated with HSV-2 acquisition in HIV patients. All other risk factors such as history of transactional sex, age at sexual debut and condom use were not significant. The results highlight the potential public health impact of HSV-2 particularly in a developing country like Nigeria where HSV-2 testing is not included in our testing and treatment protocol for HIV. This result should lead to commencement of HSV type-specific serological testing in the HIV infected population and also high risk groups should be targeted for behavioral modification messages.